Evidence map›Paper›PMID 36432070›Full record

ArticleMolecules (Basel, Switzerland)2022

Exploring the Inhibition of Quercetin on Acetylcholinesterase by Multispectroscopic and In Silico Approaches and Evaluation of Its Neuroprotective Effects on PC12 Cells.

Yijing Liao, Xi Mai, Xiaqing Wu, Xing Hu, Xiaoqiao Luo, Guowen Zhang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Potent Therapeutic Insights FromFood science & nutrition · 2026
    Article
  5. Article
  6. Investigating the Anti-Inflammatory Activity ofFoods (Basel, Switzerland) · 2026
    Article
  7. Alzheimer's disease prevention by flavonols and their analogs.The journal of prevention of Alzheimer's disease · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Exploring the Utility ofFood science & nutrition · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yijing LiaoState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Xi MaiSchool of Pharmaceutical Science, Nanchang University, Nanchang 330006, China.
Xiaqing WuState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Xing HuState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Xiaoqiao LuoState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Guowen ZhangState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.ORCID 0000-0003-2447-3729
Nanchang University · CN

Funding

the National Natural Science Foundation of China 22078143the Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University SKLF-KF-202019the Traditional Chinese Medicine Science and Technology Project of Jiangxi Province 2021A337
6 · The paper itself

Abstract

This study investigated the inhibitory mechanism of quercetin in acetylcholinesterase (AChE) and its neuroprotective effects on β-amyloid

Indexed as

AcetylcholinesteraseNeuroprotective AgentsAnimalsCholinesterase InhibitorsPC12 CellsQuercetinRatsAcetylcholinesteraseCholinesterase InhibitorsNeuroprotective AgentsQuercetinacetylcholinesterasecomputational dockinginhibitory mechanismoxidative stressquercetin

Identifiers

PMID36432070
PMCPMC9699400
OpenAlexW4309455172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.